Jacqueline Claudia Barrientos, MD
Combinations with chemotherapy and immunotherapy have historically not been an attractive approach for elderly patients with chronic lymphocytic leukemia (CLL), due to the comorbidities these patients likely already have.
OncLive: Can you provide an overview of your presentation on the management of elderly patients with CLL?
The most important thing to understand is that elderly patients have many comorbidities that may affect their ability to tolerate a particularly therapy in CLL. By the time that these patients require therapy, most of them have at least 4 comorbidities, such as high blood pressure, cardiac disease, or are at high risk for kidney or liver disease.
... to read the full story